Caprion Proteomics

Caprion’s leading and proprietary proteomics discovery technologies - CellCarta® - enable the discovery of novel targets for therapeutics development and the identification of novel protein biomarkers that can significantly reduce risk and enhance clinical development productivity and decision making in Pharmaceutical research.

Caprion Proteomics wins Frost & Sullivan Award

Details of the award in PDF

U.S. National Institutes of Health (NIH) choose Caprion's distinctive, quantitative protein profiling technologies to analyze pathogen and host proteins involved during Brucella (a potential bioterrorism agent) infection.

Click here for details.

Meeting Announcement:

http://www.tri-conference.com/

Ranks Caprion as "fast 15" within life sciences companies. (more...)

News

January 15, 2008: Caprion article in Genetic Engineering & biotechnology News: "Capitalizing on Biomarker Discovery Work" January 15th 2008 issue (Volume 28, Number 2)

January 1, 2008: Caprion article in Genetic Engineering & biotechnology News: "Unlocking the Secrets of Protein Profiling" January 1st 2008 issue (Volume 28, Number 1)

›› archive

Events

August 13 - 15, 2008: Targeted Immunotherapy and Vaccines 2008, Didier Jean-Francois attending(booth)

September 15, 2008

CHI: Biomarker Discovery Summit, Didier Jean-Francois present(booth)

Philadelphia, USA

November 17 - 19, 2008

BIO Europe; Didier Jean-Francois attending

Manheim/Heidelberg, Germany

›› archive